Systematic Critical Review of Economic Evaluations of Rituximab, Added to Conventional Chemotherapy Regimen in the Treatment of Patients with Chronic Lymphocytic Leukemic Refractory
Abstract
Authors
C.D.N. Koury A.A. Nunes M. Nita